• Air Traffic Control
  • Annual Highway Report
  • Open Enrollment
  • Events
  • Reason facebook
  • Reason twitter
  • Reason youtube
Reason Foundation
  • About
    • About Us
    • Contact Us
    • Email Newsletters
    • Events
    • FAQs
    • Jobs & Internships
    • Savas Award
    • Shop
    • Staff
    • Trustees & Officers
  • Experts

      Browse Our Experts

      • Aaron Smith
        Director of Education Reform
      • Adrian Moore
        Vice President, Policy
      • Baruch Feigenbaum
        Senior Managing Director, Transportation Policy
      • Geoff Lawrence
        Research Director
      • Guy Bentley
        Director of Consumer Freedom
      • Leonard Gilroy
        Vice President, Government Reform
      • Robert Poole
        Director of Transportation Policy
      • Vittorio Nastasi
        Director of Criminal Justice Policy
      • View All Experts
  • Topics

      Browse Our Topics

      • Air Traffic Control
      • Annual Highway Report
      • Consumer Freedom
      • Criminal Justice Reform
      • Drug Policy
      • Education
      • Gov’t Financial Transparency
      • Pension Reform
      • Technology
      • Transportation
      • Urban Growth and Land Use
      • View All Topics
  • Publications
    • Latest
    • Annual Highway Report
    • Annual Pension Report
    • Annual Privatization Report
    • Aviation Newsletter
    • Backgrounders
    • Commentaries
    • Data Visualization
    • Education Newsletter
    • Email Newsletters
    • Government Financial Project
    • Pension Reform Newsletter
    • Policy Studies
    • Psychedelics Newsletter
    • Public Schools Without Boundaries
    • Testimony
    • Transportation Newsletter
    • Amicus Briefs
  • Reason.com
  • Donate
    • Donate Online
    • Donate Crypto
    • Ways To Give
    • Torchbearer Society
    • Planned Giving

Topics › Drug Policy

Drug Policy

  • Ibogaine
  • Industrial Hemp
  • Marijuana Regulations
  • Medical Marijuana
  • Opioid Crisis
  • Psychedelics

  • State psychedelics legalization and policy roundup — March 2026
    State psychedelics legalization and policy roundup — March 2026

    Commentary by Gregory Ferenstein

  • Technology can help shift overdose prevention and response to more effective harm-reduction strategies
    Technology can help shift overdose prevention and response to more effective harm-reduction strategies

    Commentary by Ben Scher and Layal Bou Harfouch

  • Virginia’s proposed cannabis labor peace mandate violates federal law
    Virginia’s proposed cannabis labor peace mandate violates federal law

    Testimony by Geoffrey Lawrence

  • U.S. v. Hemani: Federal ban on firearm possession by unlawful drug users violates the Second Amendment
    U.S. v. Hemani: Federal ban on firearm possession by unlawful drug users violates the Second Amendment

  • Ohio should regulate kratom-related products for adult use instead of pursuing overly restrictive bans
    Ohio should regulate kratom-related products for adult use instead of pursuing overly restrictive bans

    Testimony by Madison Carlino

  • New Hampshire could expand access to psilocybin
    New Hampshire could expand access to psilocybin

    Testimony by Madison Carlino and Kaitlyn Boecker

  • Cannabusiness lawsuit highlights need for Congress to clarify federal treatment of marijuana
    Cannabusiness lawsuit highlights need for Congress to clarify federal treatment of marijuana

    Commentary by Geoffrey Lawrence

  • What is 7-OH and why did the FDA seize this potentially life-saving substance?
    What is 7-OH and why did the FDA seize this potentially life-saving substance?

    Commentary by Geoffrey Lawrence

  • Ohio’s reckless kratom ban could create new public safety concerns and grow the illegal market 
    Ohio’s reckless kratom ban could create new public safety concerns and grow the illegal market 

    Commentary by Michelle Minton

More Drug Policy

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • ...
  • 58
  • Next

Follow

  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • RSS

Email Updates

Get weekly updates from Reason.

This field is for validation purposes and should be left unchanged.

More About Reason Foundation

  • About
  • Contact
  • Donate
  • Email Newsletters
  • Events
  • Jobs and Internships
  • Policy Research
  • Reason magazine
  • Shop

Contact

Reason Foundation
5737 Mesmer Ave.
Los Angeles, CA 90230
(310) 391-2245

1630 Connecticut Ave NW
Suite 600
Washington, DC 20009
(202) 986-0916

Privacy Policy
Accessibility

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
Copyright © 2026 Reason Foundation